FDA inspection
Changzhou Jintan Qianyao Pharmaceutical Raw Materials: FDA inspection ending Feb 17, 2017
FDA inspection 1002329 · Official Action Indicated (OAI) · Jintan
Key facts
| Inspection ID | 1002329 |
|---|---|
| Firm | Changzhou Jintan Qianyao Pharmaceutical Raw Materials |
| FEI number | 3005587213 |
| Address | No. 678 Zhuangcheng, Chengzhou |
| City | Jintan |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | Feb 17, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 521381 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data